A Study to Assess the Amount of Drug Levels in Blood and Safety of AZD5718 Formulations in Healthy Volunteers

NCT04210388 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease (CAD)

Interventions

DRUG: AZD5718 tablet, Formulation A
DRUG: AZD5718 tablet, Formulation B
DRUG: AZD5718 tablet, Formulation C
DRUG: AZD5718 tablet, Formulation D
DRUG: AZD5718 film-coated tablet, Reference treatment

Sponsor

AstraZeneca

Collaborators

[object Object]